Chargement en cours...

Immunosuppressive therapy with rituximab in common variable immunodeficiency

Common variable immunodeficiency (CVID) is the most frequent symptomatic primary antibody deficiency in adulthood and is characterized by the marked reduction of IgG and IgA serum levels. Thanks to the successful use of polyvalent immunoglobulin replacement therapy to treat and prevent recurrent inf...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Mol Allergy
Auteurs principaux: Pecoraro, Antonio, Crescenzi, Ludovica, Galdiero, Maria Rosaria, Marone, Giancarlo, Rivellese, Felice, Rossi, Francesca Wanda, de Paulis, Amato, Genovese, Arturo, Spadaro, Giuseppe
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2019
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6501382/
https://ncbi.nlm.nih.gov/pubmed/31080365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12948-019-0113-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!